Almac Initiates Talks With FDA; Plans to Market Colorectal Recurrence Dx in 2008

Almac Diagnostics, previously known as ArraDx, has been an Affymetrix GeneChip service provider for years and recently began introducing its own line of array research tools called Disease Specific Arrays for colorectal, breast, and lung cancer, all manufactured by Affy on its platform.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.